Building on a successful 2024, MediWound Ltd. (MDWD) looks forward to continuing its progress in 2025, fueled by groundbreaking innovations in wound and burn management therapies.
The company has released its financial results for the fourth quarter and full year of 2024, and shares are up over 19% at $22 in premarket trading today.
Subscribe to continue reading the article.
This article is part of our premium content offering.Subscribe with a RTTNews subscription.
Subscribe NowAlready subscribed? Sign in
For comments and feedback: editorial@rttnews.com